Bioinicia changes the way poorly bioavailable drugs are formulated. Bioinicia is a specialty CDMO with drug delivery solutions to address low bioavailability of active pharmaceutical ingredients (API).
Bioinicia´s proprietary, low-temperature encapsulation technology produces ultrathin fibres or fine particles. APIs are processed into highly dispersed, submicron particles of amorphous form within polymer matrices. Fibre/particle matrices are selected to provide optimized release of the bioactives. Their fibre/particle products seamlessly integrate with standard industrial tabletting or film processing technologies.
Bioinicia’s technology is currently being used in the production of patches for transdermal/transmucosal administration, for tablet pressing for oral administration and sprays for inhalation.